Atorvastatin EP Impurity D (Mixture of D1 & D2)
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Atorvastatin EP Impurity D (Mixture of D1 & D2)

● Auf Lager

Katalog-Nr.::VE0022694
CAS-Nr.::N/A
Summenformel::C26H22FNO4 : C26H24FNO5
Molare Masse::431.5 : 449.5 g/mol

Zusätzliche Informationen zu Atorvastatin EP Impurity D (Mixture of D1 & D2)

Parent drug

Atorvastatin

IUPAC-Name

Mixture of (2E, 3E)-3-(4-fluorobenzoyl)-2-(2-methylpropanoyl)-N, 3-diphenyloxirane-2-carboxamide (D1) and (1E, 2E, 4E, 5E)-4-(4-fluorophenyl)-2, 4-dihydroxy-N, 5-diphenyl-2-(propan-2-yl)-3, 6-dioxabicyclo[3.1.0]hexane-1-carboxamide (D2) (as per EP)

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

InChI

Beschreibung

The compound Atorvastatin EP Impurity D (Mixture of D1 & D2) is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Atorvastatin. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url